A compounded form of imiquimod, a topical immune response modifier, showed promise as a treatment for ocular surface ...

Bristol Myers Squibb today announced the presentation of more than 95 data disclosures, including 27 oral presentations, across company-sponsored studies and external collaborations at the 67th ...